Nello Mainolfi, Chief Executive Officer at Kymera Therapeutics, Inc. (KYMR), sold 13,412 shares at $60.03 ($806K) on 2021-08-04, disclosed to the SEC on 2021-08-05.
Open-market sale of $806k KYMR by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.07 | 5,669 | $341K | 42.3% |
| 2 | $60.07 | 5,669 | $341K | 42.3% |
| 3 | $60.03 | 1,037 | $62K | 7.7% |
| 4 | $60.03 | 1,037 | $62K | 7.7% |
| Total | $60.06 avg | 13,412 | $806K | 100% |
| Filing → |
| KYMR | SELL | 2026-07-02 | $9.2M | — | Filing → |
| KYMR | SELL | 2026-04-29 | $2.4M | — | Filing → |
| KYMR | SELL | 2026-02-25 | $2.7M | — | Filing → |